サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1428014

低分子イノベーターCDMOの世界市場レポート 2024年

Small Molecule Innovator CDMO Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
低分子イノベーターCDMOの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

低分子イノベーターCDMOの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.0%の年間複合成長率（CAGR）で764億6,000万米ドルに成長すると予想されます。予測期間で予想される成長は、個別化医療と標的療法の台頭、エコケミストリーと持続可能性への注目の高まり、新薬の市場投入までの時間の短縮に対する需要、バイオ医薬品の拡大などの要因に起因すると考えられます。パイプラインと先進的な治療法の出現。予測期間中に予想される主要動向には、仮想とリモート開発モデルの台頭、製薬業界におけるコラボレーションとパートナーシップの増加、新興市場へのCDMOサービスの拡大、製造におけるシングルユース技術の利用、CDMOの進化が含まれます。

小分子イノベーターCDMO市場の成長は、慢性疾患の有病率の増加によって促進されると予想されます。1年以上続き、継続的な治療が必要となる慢性疾患が増加しています。低分子イノベーターCDMO市場は、慢性疾患用の医薬品の製造において重要な役割を果たし、製薬会社やバイオテクノロジー企業にサービスを提供しています。 2023年1月の国立バイオテクノロジー情報センター（NCBI）の予測によると、米国で少なくとも1つの慢性疾患を持つ50歳以上の人の数は2050年までに99.5%急増し、1億4,266万人に達すると予想されています。したがって、慢性疾患の有病率の増加は、低分子イノベーターCDMO市場の推進力として機能します。

低分子イノベーターCDMO市場の成長に寄与すると予想される要因は、研究開発（R&D）への支出の増加です。研究開発支出には、イノベーション、製品開発、技術進歩を目的とした活動のために企業または組織によって割り当てられる資金が含まれます。低分子イノベーターCDMO市場は、製薬会社やバイオテクノロジー会社に専門的かつ効率的なサービスを提供することで研究開発支出の増加をサポートし、創薬と開発プロセスの迅速化を促進します。特に、2023年 1月、国立科学工学統計センター（NCSES）は、米国の研究開発支出が大幅に増加し、2020年には7,170億米ドルに達し、2021年には7,920億米ドルに増加すると推定されていると報告しました。総額4,717億米ドルは実験開発に向けられ、研究開発費総額の66％を占めました。したがって、研究開発費の増加軌道は、低分子イノベーターCDMO市場の促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の低分子イノベーターCDMO市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の低分子イノベーターCDMOの市場規模実績と成長、2018～2023年
  • 世界の低分子イノベーターCDMO市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の低分子イノベーターCDMO市場、製品別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 低分子医薬品有効成分（API）
  • 低分子医薬品
  • 世界の低分子イノベーターCDMO市場、段階別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 前臨床
  • 臨床
  • 商用
  • 世界の低分子イノベーターCDMO市場、治療別、実績と予測別セグメンテーション、2018～2023年、2023～2028年、2033年
  • 循環器疾患
  • 腫瘍
  • 呼吸器疾患
  • 神経内科
  • 代謝障害
  • 感染症
  • その他
  • 世界の低分子イノベーターCDMO市場、顧客別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 医薬品
  • バイオテクノロジー

第7章 地域と国の分析

  • 世界の低分子イノベーターCDMO市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の低分子イノベーターCDMO市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 低分子イノベーターCDMO市場の競合情勢
  • 低分子イノベーターCDMO市場の企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Boehringer Ingelheim International GmbH
    • Evonik Industries AG
    • Lonza Group Ltd.
    • Labcorp Drug Development

第31章 その他の大手と革新的な企業

  • Catalent Inc.
  • Wuxi AppTec Co. Ltd.
  • Asymchem
  • Siegfried holdings
  • Recipharm AB
  • Almac Sciences Ltd.
  • Curia Global Inc.
  • Cambrex Corporation
  • Piramal Pharma Ltd.
  • Hovione
  • Corden Pharma GmbH
  • Alcami Corporation
  • Lifecore Biomedical Inc.
  • NovaTech LLC
  • Mikart LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r13858

A small molecule innovator Contract Development and Manufacturing Organization (CDMO) refers to a pharmaceutical division that provides contract services for the development and manufacturing of small-molecule drugs. These services are often utilized in clinical trials to gather early relative bioavailability information.

The main product types offered by small molecule innovator CDMOs include small molecule active pharmaceutical ingredient (API) and small molecule drug product. Small molecule API refers to any material or combination of materials intended to be used as an active component in the production of a medication or medical product. The various stages involved in the development and manufacturing process include preclinical, clinical, and commercial stages, and these products are used in therapeutic areas such as cardiovascular disease, oncology, respiratory disorders, neurology, metabolic disorders, infectious disease, and others. The primary customers for small molecule innovator CDMOs are pharmaceutical and biotechnology companies.

The small molecule innovator CDMO market research report is one of a series of new reports from The Business Research Company that provides small molecule innovator CDMO market statistics, including small molecule innovator CDMO industry global market size, regional shares, competitors with a small molecule innovator CDMO market share, detailed small molecule innovator CDMO market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule innovator CDMO industry. This small molecule innovator CDMO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small molecule innovator cdmo market size has grown strongly in recent years. It will grow from $51.84 billion in 2023 to $56.13 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historical period can be attributed to factors such as the rising demand for outsourcing services, the increasing complexity of small molecule drugs, a heightened focus on reducing time-to-market, cost pressures on pharmaceutical companies, and the need to comply with stringent regulatory requirements.

The small molecule innovator cdmo market size is expected to see strong growth in the next few years. It will grow to $76.46 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The anticipated growth in the forecast period can be attributed to factors such as the rise in personalized medicine and targeted therapies, an increased focus on green chemistry and sustainability, the demand for faster time-to-market for new drugs, the expansion of the biopharmaceutical pipeline, and the emergence of advanced therapies. Key trends expected in the forecast period encompass the rise of virtual and remote development models, increased collaboration and partnerships in the pharmaceutical industry, the expansion of CDMO services to emerging markets, the utilization of single-use technologies in manufacturing, and the evolution of CDMOs into strategic development partners.

The growth of the small-molecule innovator CDMO market is expected to be fueled by the increasing prevalence of chronic diseases. Chronic diseases, which last a year or longer and often require continuous medical care, are on the rise. The small-molecule innovator CDMO market plays a crucial role in manufacturing medicines for chronic diseases, providing services to pharmaceutical and biotech companies. Projections from the National Center for Biotechnology Information (NCBI) in January 2023 indicate that by 2050, the number of individuals aged 50 and older with at least one chronic illness in the US is anticipated to surge by 99.5%, reaching 142.66 million, up from 71.522 million in 2020. Thus, the increasing prevalence of chronic diseases serves as a driving force for the small-molecule innovator CDMO market.

A factor expected to contribute to the growth of the small-molecule innovator CDMO market is the rising expenditures on research and development (R&D). Research and Development expenditures involve financial resources allocated by companies or organizations for activities aimed at innovation, product development, and technological advancements. The small-molecule innovator CDMO market supports increased R&D spending by offering specialized and efficient services to pharmaceutical and biotechnology companies, facilitating expedited drug discovery and development processes. Notably, in January 2023, the National Center for Science and Engineering Statistics (NCSES) reported a substantial increase in R&D expenditures in the US, reaching $717 billion in 2020 and an estimated rise to $792 billion in 2021. A significant portion of these expenditures, totaling $471.7 billion, was directed towards experimental development, constituting 66% of the total R&D spending. Therefore, the upward trajectory of R&D expenditures is a driving factor for the small-molecule innovator CDMO market.

A prominent trend in the small-molecule CDMO market is the focus on product innovation. Major companies within this market are adopting innovative products to sustain their positions. In May 2023, Oxford Biomedica, a UK-based company, introduced TetraVecta, a next-generation system for CDMO. This technology addresses previous challenges in medicinal development related to payload size, complexity, or interference, thereby facilitating the advancement of in vivo gene treatments.

Strategic partnerships are emerging as a key approach for major companies in the small-molecule innovator CDMO market to provide contract development and manufacturing organization (CDMO) services. Strategic partnerships involve leveraging each other's strengths and resources for mutual benefits and success. An example of this approach is the partnership between SST Corporation, a US-based pharmaceutical company, and Viwit Pharmaceuticals, a China-based research-based pharmaceutical and chemical company. Through this collaboration, they aim to enhance market growth in North America by expanding offerings, leveraging expertise, increasing capacity, and providing essential regulatory support to strengthen their competitive edge.

In February 2022, Recipharma AB, a Sweden-based pharmaceutical CDMO, acquired Vibalogics for an undisclosed amount. This acquisition allows Recipharm to utilize Vibalogics' expertise in oncolytic viruses, viral vaccines, and viral vector gene treatments, enabling diversification across multiple technologies and modalities. Vibalogics GmbH is a Germany-based pharmaceutical CDMO.

Major companies operating in the small molecule innovator cdmo market report are Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, Evonik Industries AG, Lonza Group Ltd. , Labcorp Drug Development, Catalent Inc., Wuxi AppTec Co. Ltd., Asymchem, Siegfried holdings, Recipharm AB, Almac Sciences Ltd., Curia Global Inc., Cambrex Corporation, Piramal Pharma Ltd., Hovione, Corden Pharma GmbH, Alcami Corporation, Lifecore Biomedical Inc., NovaTech LLC, Mikart LLC, Kymanox Corporation, August Bioservices LLC, Lyophilization Technology Inc., LGM Pharma LLC, INCOG BioPharma Services

Asia-Pacific was the largest region in the small molecule innovator CDMO market in 2023. The regions covered in the small molecule innovator cdmo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the small molecule innovator cdmo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small molecule innovator CDMO market includes revenues earned by entities by manufacturing the drug substance and providing innovation and services such as packaging, serialization, and shipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Molecule Innovator CDMO Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule innovator cdmo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule innovator cdmo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small molecule innovator cdmo market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Small Molecule Active Pharmaceutical Ingredient (API); Small Molecule Drug Product
  • 2) By Stage: Preclinical; Clinical; Commercial
  • 3) By Therapeutic: Cardiovascular Disease; Oncology; Respiratory Disorders; Neurology; Metabolic Disorders; Infectious Disease; Other Therapeutics
  • 4) By Customer: Pharmaceutical; Biotechnology
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Boehringer Ingelheim International GmbH; Evonik Industries AG; Lonza Group Ltd. ; Labcorp Drug Development
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Small Molecule Innovator CDMO Market Characteristics

3. Small Molecule Innovator CDMO Market Trends And Strategies

4. Small Molecule Innovator CDMO Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Small Molecule Innovator CDMO Market Size and Growth

  • 5.1. Global Small Molecule Innovator CDMO Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Small Molecule Innovator CDMO Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Small Molecule Innovator CDMO Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Small Molecule Innovator CDMO Market Segmentation

  • 6.1. Global Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Small Molecule Active Pharmaceutical Ingredient(API)
  • Small Molecule Drug Product
  • 6.2. Global Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Preclinical
  • Clinical
  • Commercial
  • 6.3. Global Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiovascular Disease
  • Oncology
  • Respiratory Disorders
  • Neurology
  • Metabolic Disorders
  • Infectious Disease
  • Other Therapeutics
  • 6.4. Global Small Molecule Innovator CDMO Market, Segmentation By Customer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical
  • Biotechnology

7. Small Molecule Innovator CDMO Market Regional And Country Analysis

  • 7.1. Global Small Molecule Innovator CDMO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Small Molecule Innovator CDMO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Small Molecule Innovator CDMO Market

  • 8.1. Asia-Pacific Small Molecule Innovator CDMO Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Small Molecule Innovator CDMO Market

  • 9.1. China Small Molecule Innovator CDMO Market Overview
  • 9.2. China Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Small Molecule Innovator CDMO Market

  • 10.1. India Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Small Molecule Innovator CDMO Market

  • 11.1. Japan Small Molecule Innovator CDMO Market Overview
  • 11.2. Japan Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Small Molecule Innovator CDMO Market

  • 12.1. Australia Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Small Molecule Innovator CDMO Market

  • 13.1. Indonesia Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Small Molecule Innovator CDMO Market

  • 14.1. South Korea Small Molecule Innovator CDMO Market Overview
  • 14.2. South Korea Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Small Molecule Innovator CDMO Market

  • 15.1. Western Europe Small Molecule Innovator CDMO Market Overview
  • 15.2. Western Europe Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Small Molecule Innovator CDMO Market

  • 16.1. UK Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Small Molecule Innovator CDMO Market

  • 17.1. Germany Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Small Molecule Innovator CDMO Market

  • 18.1. France Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Small Molecule Innovator CDMO Market

  • 19.1. Italy Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Small Molecule Innovator CDMO Market

  • 20.1. Spain Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Small Molecule Innovator CDMO Market

  • 21.1. Eastern Europe Small Molecule Innovator CDMO Market Overview
  • 21.2. Eastern Europe Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Small Molecule Innovator CDMO Market

  • 22.1. Russia Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Small Molecule Innovator CDMO Market

  • 23.1. North America Small Molecule Innovator CDMO Market Overview
  • 23.2. North America Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Small Molecule Innovator CDMO Market

  • 24.1. USA Small Molecule Innovator CDMO Market Overview
  • 24.2. USA Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Small Molecule Innovator CDMO Market

  • 25.1. Canada Small Molecule Innovator CDMO Market Overview
  • 25.2. Canada Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Small Molecule Innovator CDMO Market

  • 26.1. South America Small Molecule Innovator CDMO Market Overview
  • 26.2. South America Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Small Molecule Innovator CDMO Market

  • 27.1. Brazil Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Small Molecule Innovator CDMO Market

  • 28.1. Middle East Small Molecule Innovator CDMO Market Overview
  • 28.2. Middle East Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Small Molecule Innovator CDMO Market

  • 29.1. Africa Small Molecule Innovator CDMO Market Overview
  • 29.2. Africa Small Molecule Innovator CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Small Molecule Innovator CDMO Market, Segmentation By Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Small Molecule Innovator CDMO Market, Segmentation By Therapeutic, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Small Molecule Innovator CDMO Market Competitive Landscape And Company Profiles

  • 30.1. Small Molecule Innovator CDMO Market Competitive Landscape
  • 30.2. Small Molecule Innovator CDMO Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Boehringer Ingelheim International GmbH
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Evonik Industries AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Lonza Group Ltd.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Labcorp Drug Development
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Small Molecule Innovator CDMO Market Other Major And Innovative Companies

  • 31.1. Catalent Inc.
  • 31.2. Wuxi AppTec Co. Ltd.
  • 31.3. Asymchem
  • 31.4. Siegfried holdings
  • 31.5. Recipharm AB
  • 31.6. Almac Sciences Ltd.
  • 31.7. Curia Global Inc.
  • 31.8. Cambrex Corporation
  • 31.9. Piramal Pharma Ltd.
  • 31.10. Hovione
  • 31.11. Corden Pharma GmbH
  • 31.12. Alcami Corporation
  • 31.13. Lifecore Biomedical Inc.
  • 31.14. NovaTech LLC
  • 31.15. Mikart LLC

32. Global Small Molecule Innovator CDMO Market Competitive Benchmarking

33. Global Small Molecule Innovator CDMO Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Small Molecule Innovator CDMO Market

35. Small Molecule Innovator CDMO Market Future Outlook and Potential Analysis

  • 35.1 Small Molecule Innovator CDMO Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Small Molecule Innovator CDMO Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Small Molecule Innovator CDMO Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer